# Arginine methylation of N protein is required for its RNA binding capacity, since treatment with a type I PRMT inhibitor (MS023) 
# or substitution of R95K or R177K inhibited interaction with the 5’-UTR of the SARS-CoV-2 genomic RNA.
# Cai et al. (2021) https://www.biorxiv.org/content/10.1101/2021.03.24.436822v1
R95X

# Arginine methylation of N protein is required for its RNA binding capacity, since treatment with a type I PRMT inhibitor (MS023) 
# or substitution of R95K or R177K inhibited interaction with the 5’-UTR of the SARS-CoV-2 genomic RNA.
# Cai et al. (2021) https://www.biorxiv.org/content/10.1101/2021.03.24.436822v1
R177X

# Northern blot analysis of novel mutant virus-like-particles (VLPs) shows most increase in RNA content of any N mutation tested, suggesting that this
# mutation improves virus particle production (requisite RNA packaging signal binding site in nsp15/16 boundary is included in the VLP).
# Syed et al. (2021) https://www.biorxiv.org/content/10.1101/2021.08.05.455082v1
R203M

# Northern blot analysis of novel mutant virus-like-particles (VLPs) shows major increase in RNA content with this mutation, suggesting that 
# it improves virus particle production (requisite RNA packaging signal binding site in nsp15/16 boundary is included in the VLP).
# Syed et al. (2021) https://www.biorxiv.org/content/10.1101/2021.08.05.455082v1
S202R

# Northern blot analysis of novel mutant virus-like-particles (VLPs) shows increase in RNA content with this mutation, suggesting that it
# improves virus particle production (requisite RNA packaging signal binding site in nsp15/16 boundary is included in the VLP).
# Syed et al. (2021) https://www.biorxiv.org/content/10.1101/2021.08.05.455082v1
P199L
